Clinicopathological and Molecular Characteristics of PIK3CA-mutant Gastric Cancer with Emphasis on its Tumor Immune Microenvironment

被引：0
|
作者：
Choi, Sangjoon [1 ]
Kim, Hyunjin [1 ]
Kang, Won Ki [1 ]
Kim, Kyoung-Mee [1 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2022年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
401
引用
收藏
页码：436 / 438
页数：3
相关论文
共 50 条
  • [41] Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells
    Kim, Hyun-Jung
    Lee, Soo Yoon
    Kim, Chan Young
    Kim, Yun Hwan
    Ju, Woong
    Kim, Seung Cheol
    ONCOTARGET, 2017, 8 (04) : 6608 - 6622
  • [42] Identification of novel regulators of response to PI3Ka inhibition in PIK3CA mutant gastric cancer
    Stanland, Lyla
    Ang, Hazel
    Hoj, Jacob
    Chu, Yunqiang
    Tan, Patrick
    Wood, Kris
    Luftig, Micah
    CANCER RESEARCH, 2023, 83 (07)
  • [43] The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer
    Xu, Xiao
    Zhou, Na
    Lan, Hongwei
    Yang, Fangfang
    Dong, Bowen
    Zhang, Xiaochun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [44] The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases
    Ippen, Franziska M.
    Alvarez-Breckenridge, Christopher A.
    Kuter, Benjamin M.
    Fink, Alexandria L.
    Bihun, Ivanna, V
    Lastrapes, Matthew
    Penson, Tristan
    Schmidt, Stephen P.
    Wojtkiewicz, Gregory R.
    Ning, Jianfang
    Subramanian, Megha
    Giobbie-Hurder, Anita
    Martinez-Lage, Maria
    Carter, Scott L.
    Cahill, Daniel P.
    Wakimoto, Hiroaki
    Brastianos, Priscilla K.
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3374 - 3383
  • [45] Characteristics of immunophenotypes and immunological in tumor microenvironment and analysis of immune implication of CXCR4 in gastric cancer
    Wen, Fang
    Lu, Xiaona
    Huang, Wenjie
    Chen, Xiaoxue
    Ruan, Shuai
    Gu, SuPing
    Gu, Peixing
    Li, Ye
    Liu, Jiatong
    Liu, Shenlin
    Shu, Peng
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Characteristics of immunophenotypes and immunological in tumor microenvironment and analysis of immune implication of CXCR4 in gastric cancer
    Fang Wen
    Xiaona Lu
    Wenjie Huang
    Xiaoxue Chen
    Shuai Ruan
    SuPing Gu
    Peixing Gu
    Ye Li
    Jiatong Liu
    Shenlin Liu
    Peng Shu
    Scientific Reports, 12
  • [47] Reactivation of SYTL3 reshapes the anti-tumor immune microenvironment in gastric cancer
    Chan, Michael
    Low, Jie T.
    CANCER SCIENCE, 2025, 116 : 947 - 947
  • [48] PIPA: A phase Ib study of β-isoform sparing phosphatidylinositol 3-kinase (PI3K) inhibitor taselisib (T) plus palbociclib (P) and fulvestrant (FUL) in PIK3CA-mutant (mt) ER-positive and taselisib (T) plus palbociclib (P) in PIK3CA-mutant (mt) ER-negative advanced breast cancer.
    Pascual, Javier
    MacPherson, Iain R.
    Armstrong, Anne Caroline
    Ward, Sarah Emily
    Parmar, Mona
    Turner, Alison Joanne
    Bye, Hannah
    Proszek, Paula
    Dodson, Andrew
    Garcia-Murillas, Isaac
    King, Jenny
    Hall, Emma
    Finneran, Laura
    Lopez, Juanita Suzanne
    Okines, Alicia Frances Clare
    Ring, Alistair E.
    Turner, Nicholas C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Investigation of PIK3CA gene mutation in Indian breast cancer and its correlation with clinicopathological findings.
    Bhatia, Simi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
    Raphael, Ari
    Salmon-Divon, Mali
    Epstein, Jessica
    Zahavi, Tamar
    Sonnenblick, Amir
    Shachar, Shlomit S.
    GENES, 2022, 13 (10)
12345